Reperfusion therapy fails to improve limb ischemia in clinical trial

07/30/2013 | TCTMD.com

The use of controlled reperfusion techniques for patients undergoing surgical revascularization did not improve their recovery from critical limb ischemia in a randomized study of 174 patients conducted in Germany. The study showed that the rates of amputation-free survival after four weeks and one year remained the same between the controlled reperfusion group and those who just had surgery.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC